News Daily News FDA: Obesity Drug Lorcaserin Exits US Market Over Cancer Concerns Shelley Wood February 14, 2020
News Daily News CV Safety Trial for Lorcaserin Picks Up Cancer Signal: FDA Shelley Wood January 14, 2020
News Conference News ACC 2017 FDA Warns of Risk of Major Adverse Cardiac Events With Absorb BVS Michael O'Riordan March 18, 2017